ѧÊõÌÃÊ×Ò³ | ÎÄÏ×ÇóÖúÂÛÎÄ·¶ÎÄ | ÂÛÎÄÌâÄ¿ | ²Î¿¼ÎÄÏ× | ¿ªÌⱨ¸æ | ÂÛÎĸñʽ | ÕªÒªÌá¸Ù | ÂÛÎÄÖÂл | ÂÛÎIJéÖØ | ÂÛÎÄ´ð±ç | ÂÛÎÄ·¢±í | ÆÚ¿¯ÔÓÖ¾ | ÂÛÎÄд×÷ | ÂÛÎÄPPT
ѧÊõÌÃרҵÂÛÎÄѧϰƽ̨Äúµ±Ç°µÄλÖãºÑ§ÊõÌà > ҽѧÂÛÎÄ > ÁÙ´²Ò½Ñ§ÂÛÎÄ > ¸¾²ú¿ÆÂÛÎÄ

Á÷²ú»¼ÕßÄýѪ״̬¶ÔÁ÷²úµÄÓ°Ïì·ÖÎö

À´Ô´£ºÑªË¨ÓëֹѪѧ ×÷Õߣº³ÂÓ¢,¹¨²¨,Àî¿¡,ºúл
·¢²¼ÓÚ£º2021-10-18 ¹²2062×Ö

¡¡¡¡Õª    Òª£º¡¡Ä¿µÄ ̽ÌÖÁ÷²úÓëÄýѪ¹¦ÄܵĵĹØϵ¡£·½·¨ Ñ¡Ôñ2018Äê1Ô¡«2020Äê12Ô¾ÍÕïÓÚÎÒÔºµÄ60Àý²»Ã÷Ô­ÒòÁ÷²ú»¼ÕßΪ¹Û²ì×飬ͬÆÚ60Àý½¡¿µÕßΪ¶ÔÕÕ×é¡£²â¶¨ÄýѪʱ¼ä(aPTT,PT,TT)ÏËάµ°°×Ô­(Fbg)¡¢D¶þ¾ÛÌå(DD)¡¢ÑªÐ¡°å¼ÆÊýÓë¾Û¼¯ÂÊ¡£±È½ÏÆä²â¶¨½á¹û¡£½á¹û Óë¶ÔÕÕ×éÏà±È:¹Û²ì×éÄýѪʱ¼ä(aPTT,PT,TT)Ëõ¶Ì(P<0.05)£¬ÏËάµ°°×Ô­(Fbg)¡¢D¶þ¾ÛÌå(D-D)Éý¸ß(P<0.05)¡¢ÑªÐ¡°å¼ÆÊýÓë¾Û¼¯ÂÊÉϵ÷(P<0.05)¡£½áÂÛ Á÷²ú»¼ÕßÄýѪѪ¼ì²é¾ùÏÔʾ¸ßÄý״̬£¬²ÉÈ¡Ô¤·ÀÐÔ´ëÊ©¸ÄÉÆÄýѪ¹¦ÄÜ£¬¿ÉÄÜÔ¤·ÀÁ÷²úµÄ·¢Éú¡£

¡¡¡¡¹Ø¼ü´Ê :     Á÷²ú;ÄýѪָ±ê;

¡¡¡¡Abstract£º¡¡Objective To explore the relationship between abortion and blood clotting function. Methods 60 unexplained abortion patients who were treated in our hospital from January 2018 to December 2020 were selected as the observation group,and 60 healthy patients who had health check-ups during the same period were in the control group. The coagulation time (aPTT,PT,TT) fibrinogen (Fbg),D dmimer (D-D),plate plate count and aggregation rate were measured. Compare the results of its measurements. Results Compared with the control group,the blood clotting time (aPTT,PT,TT) was shortened (P < 0. 05),Fbg¡¢D-D was elevated (P < 0. 05),plateplate count and aggregation rate was increased (P< 0. 05). Conclusion The blood clotting examination of abortion patients showed high coagulation status,preventive measures were taken to improve the blood clotting function,and pre-abortion may occur.

¡¡¡¡Keyword£º¡¡Abortion; Coagulation indicator;

¡¡¡¡Á÷²úÊDzú¿Æ³£¼û¼²²¡Ö®Ò»£¬Æ䲡Òò½ÏΪ¸´ÔÓ[1]¡£½üÄê¹Û²ì·¢ÏÖѪҺ¸ßÄý״̬ÔÚÁ÷²ú·¢²¡ÖÐÓÐÒ»¶¨µÄ×÷ÓÃ[2]¡£±¾ÎÄÑ¡Ôñ2018Äê1Ô¡«2020Äê12Ô¾ÍÕïÓÚÎÒÔºµÄ60ÀýÁ÷²ú»¼Õߣ¬Óë60Àý½¡¿µÔи¾¶Ô±È£¬¹Û²ìÁ½×鲡ÀýÄýѪ¹¦ÄÜÇø±ð£¬Ì½Ã÷¸ßÄý״̬ÓëÁ÷²úµÄ¹Øϵ¡£

¡¡¡¡1¡¢×ÊÁÏÓë·½·¨

¡¡¡¡1.1¡¢ Ò»°ã×ÊÁÏ

¡¡¡¡Ñ¡Ôñ2018Äê1Ô¡«2020Äê12Ô¾ÍÕïÓÚÎÒÔºµÄ60ÀýÁ÷²ú»¼ÕßΪ¹Û²ì×飬ÄêÁä22¡«30(24.62¡À4.12)Ëê¡£½¡¿µÔи¾60ÀýΪ¶ÔÕÕ×飬ÄêÁä21¡«31(24.36¡À4.24)Ëê¡£Åųý±ê×¼:ѪҺϵͳ¡¢×ÔÉíÃâÒßϵͳ¼²²¡¡¢Ö×ÁöÀ༲²¡;½üÆÚ·þÓñÜÔÐÒ©ÓëÓ°ÏìÄýѪϵͳÓëѪС°å»îÐÔÒ©Îï¡£Á½×éÒ»°ã×ÊÁ϶Աȣ¬²îÒìÎÞÏÔ×ÅÐÔ(P>0.05)¡£

¡¡¡¡1.2¡¢ Ñо¿·½·¨

¡¡¡¡1.2.1 ¡¢¼ì²âÒÇÆ÷·½·¨(1)È«×Ô¶¯ÑªÄý·ÖÎöÒÇ(ACL TOP-700)¼ì²â»î»¯²¿·ÖÄýѪ»îøʱ¼ä(activated partial prothrombin time,a PTT)¡¢ÄýѪøԭʱ¼ä(prothrombin time,PT)¡¢ÄýѪøʱ¼ä(thrombin time,TT)¡¢ÏËάµ°°×Ô­(fibrinogen,Fbg)ˮƽ¡¢D¶þ¾ÛÌå(D-dimer,D-D)¡£(2)Ѫϸ°û·ÖÎöÒÇ(Sysmex XN-1000)¼ÆÊýѪС°å×ÜÊý¡¢(3)ѪС°åADP¾Û¼¯ÒÇ(Chrono-log Model 700)¼ì²âѪС°åADP¾Û¼¯ÂÊ(PAg T)

1.png

¡¡¡¡1.2.2 ¡¢·ÖÎö¶Ô±ÈÁ½×éÏà¹Ø¼ì²âÖ¸±êµÄ²îÒì

¡¡¡¡1.3¡¢ ͳ¼Æѧ´¦Àí

¡¡¡¡Ó¦ÓÃSPSS 21.0ͳ¼ÆÈí¼þ¶ÔÊý¾Ý·ÖÎö£¬¼ÆÊý×ÊÁÏÒÔn(%)±íʾ£¬¿¨·½(¦Ö2)¼ìÑ飬¼ÆÁ¿×ÊÁÏÓñíʾ£¬t¼ìÑ飬P<0.05ʾ²îÒìÓÐͳ¼ÆѧÒâÒå¡£

¡¡¡¡2 ¡¢½á¹û

¡¡¡¡2.1 ¡¢Á½×éÄýѪʱ¼äÖ¸±ê¶Ô±È(±í1)

¡¡¡¡¹Û²ì×é¾ùµÍÓÚ¶ÔÕÕ×é(P<0.05)£¬±íÃ÷¹Û²ì×éÏà¶Ô¸ßÄý¡£

¡¡¡¡±í1 Á½×éÄýѪʱ¼äÖ¸±ê¶Ô±È

GetImg (1).jpg

¡¡¡¡2.2¡¢ Á½×éFbg¡¢D-D¡¢BPC¡¢PAg Tˮƽ¶Ô±È(±í2)

¡¡¡¡¹Û²ì×é¸÷ÏîÖ¸±ê¾ù¸ßÓÚ¶ÔÕÕ×é(P<0.05)¡£

¡¡¡¡±í2

GetImg (2).jpg

¡¡¡¡3 ¡¢ÌÖÂÛ

¡¡¡¡ÄýѪ¹¦ÄÜÔö¸ßÔÚÔвú¸¾ÖÐÊÇÒ»ÖÖÉúÀí״̬£¬µ«ÔÚijЩÇé¿ö¡¢ÈçºÏ²¢ÈÑÉïÆÚ¸ßѪѹÐÔ¼²²¡¡¢ÈÑÉïÆÚÌÇÄò²¡¡¢ÃâÒßȱÏÝ¡¢¿¹Á×Ö¬×ÛºÏÕ÷µÈÒ쳣ʱ£¬¸ßÄý״̬¼ÓÖØ[3]¡£ÔÚ¸ßÄý״̬£¬¸Ä±ä×Ó¹¬Ì¥Å̲¿Î»ÑªÁ÷״̬£¬ÈÝÒ×Ðγɾֲ¿Î¢ÑªË¨£¬µ¼Ö»¼Õß³öÏÖÌ¥Å̹£ËÀ£¬¼õÉÙÌ¥ÅÌѪ¹©£¬ÅßÌ¥»òÌ¥¶ùÒòȱÑõȱѪ£¬³öÏÖ·¢Óý²»Á¼¶øÁ÷²ú[4]¡£Òò´Ë£¬ÔÚÔи¾ÔÐÆÚ¼à²âÄýѪ¹¦ÄÜÓнϴóµÄÒâÒå¡£³£¹æÄýѪʱ¼äËõ¶Ì¿É×÷Ϊ¸ßÄý״̬µÄ×ôÖ¤¡£D-DÊÇ·´Ó³ÏËÈÜϵͳ¿º½øµÄÌØÒìÐÔ¡¢Ãô¸ÐÐÔѪÇå±êÖ¾Î²¢¿É·´Ó³ÑªÒºµÄ¸ßÄý״̬¡£FbgÊôÓÚÏËάµ°°×µ¥Ìå¾ÛºÏÎÓëѪС°å¶¼ÊÇѪ˨ÐγɵÄÖØÒª»ùÖÊ¡£ÌرðÊÇѪС°å»î»¯¡¢¾Û¼¯ÂÊÔö¸ßʱ[5]¡£±¾ÎĽá¹ûÏÔʾ£¬¹Û²ì×éFbg¡¢D-D,BPC¡¢PAg T¾ùÃ÷ÏÔ¸ßÓÚ¶ÔÕÕ×飬±íÃ÷»¼Õß²»½ö´æÔÚ¸ßÄý״̬£¬ÇÒÍêÈ«¿ÉÒÔÈ϶¨¼ºÓÐ΢СѪ˨ÐγÉ[6]£¬ÈÑÉïÆÚÔи¾Ó°Ïñѧ¼ì²éÓÐËù½û¼É£¬³£¹æÒÔÄýѪʵÑé¼ì²âÈ·¶¨»¼ÕßÊÇ·ñÓÐѪ˨ÐγÉÇãÏò£¬´Ó¶øÔçÆÚ½øÐÐÔ¤·ÀÐÔÖÎÁÆ£¬·ÀÖ¹Á÷²úµÈ²»Á¼Ê¼þ·¢Éú¡£

¡¡¡¡²Î¿¼ÎÄÏ×

¡¡¡¡[1]³ÌÀö»ª,ËïÈÙ¸ï.̽ÌÖÈÑÉïÆÚ¸¾Å®ÄýѪָ±êµÄ±ä»¯ÒÔ¼°¼ì²âµÄÁÙ´²ÒâÒå[J] .ÖйúÒ½Ò©Ö¸ÄÏ, 2018,16(5):4-5.

¡¡¡¡[2]ÖÜÀöÓ¢,ÀӢ,³ÂÉÙȺ,µÈ.×ۺϻ¤Àí¸ÉÔ¤¶ÔÈÑÉïÆÚ¸ßѪѹÄýѪ¹¦ÄܵÄ×÷ÓÃ[J] .¹ú¼Ê»¤ÀíѧÔÓÖ¾, 2014, 14(8):2050-2051.

¡¡¡¡[3]Ðìºé÷.ÈÑÉïÍíÆÚÔи¾ÄýѪËÄÏî¡¢FDP. D= ¾ÛÌåµÄ±ä»¯¼°ÁÙ´²ÒâÒå[J] .ҽѧÐÂÖªÔÓÖ¾, 2017,27(5):492-493.

¡¡¡¡[4]Áºèª,Íõæºæº,ÕÔ³¿. ÔÐÍíÆÚÄýѪ¼°ÏËÈÜÏà¹ØÖ¸±ê¼ì²â¶ÔµÍΣ²ú¸¾²úºó³öѪµÄÔ¤²â¼ÛÖµ·ÖÎö[J] .¹ú¼Ê¼ìÑéҽѧÔÓÖ¾, 2017,38(21):3029-3031.

¡¡¡¡[5]¾°Ñô£¬¶¡ÃÈ,ФÑÞƽ,µÈ.ÈÑÉïÏà¹Ø¾²ÂöѪ˨˨ÈûÖ¢µÄD¶þ¾ÛÌå±ä»¯ÌØÕ÷¼°ÁÙ½çÖµÑо¿[J] .Ѫ˨ÓëֹѪѧ, 2018,24(1):51-53.

¡¡¡¡[6]ÍôÑÞÀö,ÄÜÁÁ,Õž². D-Dimer. AT-M¡¢ tPA¡¢ PAI-1ˮƽ¶Ô¸´·¢ÐÔÁ÷²ú»¼ÕßѪ˨ǰ״̬µÄÕï¶Ï¼ÛÖµ[J] . ΢ѭ»·Ñ§ÔÓÖ¾, 2016,26(3):27-30.


×÷Õßµ¥Î»£ºÉϺ£Êг¤Äþ¸¾Ó×±£½¡Ôº¼ìÑé¿Æ ÉϺ£Êг¤Äþ¸¾Ó×±£½¡Ôº²ú¿Æ
Ô­Îijö´¦£º³ÂÓ¢,¹¨²¨,Àî¿¡,ºúлӦ,¼¾µ¤,Ф´º.Á÷²úÓëÄýѪ¹¦ÄܵÄÏà¹ØÐÔÑо¿[J].Ѫ˨ÓëֹѪѧ,2021,27(06):910-911.
Ïà¹Ø±êÇ©£º
  • ±¨¾¯Æ½Ì¨
  • ÍøÂç¼à²ì
  • ±¸°¸ÐÅÏ¢
  • ¾Ù±¨ÖÐÐÄ
  • ´«²¥ÎÄÃ÷
  • ³ÏÐÅÍøÕ¾